Today comes another Derek Lowe piece on recent publications around tau in general CNS problems. Here's the punch line:
The capillaries back there are a different and more permissive population than the usual ones in the central nervous system (and thus the rapid onset of snorted drugs of abuse as well). The paper shows a single dose of this antibody in the mouse model reducing the amount of pathological tau and increasing cognitive function in the mice. Which is quite startling - you might have expected to have to go through a longer course of treatment to see something significant.That's one hell of a punch line. I said that, yes I did. Could be a lot of moolah wasted on the Aβ sink.
Looking at the authors of the various papers, didn't see any known AD companies. Yet.
No comments:
Post a Comment